BiopharmIQ
Catalyst Calendar
Big Movers™
All Big Movers™
Current Qtr Report
Future Movers Report
Historical Movers Data
PDUFA Events
PDUFA Calendar
Current PDUFA Report
Historical PDUFA Report
Company Screener
M&A Activity
Historical M&A Data
M&A Target Ideas
Meeting Calendar
Hedge Funds
Fund Screener
All Ticker Holdings
Ticker Holdings by Size
Holdings Download
Analysts & Portfolios

Biotech ChatroomMy WatchlistsMy Notes
Try Elite FreeAlready have an account? Login

Enterprise Value

15.17M

Cash

44.29M

Avg Qtr Burn

N/A

Short % of Float

3.96%

Insider Ownership

37.46%

Institutional Own.

12.90%

Qtr Updated

03/31/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
EVOMELA (melphalan) Details
MM (Multiple Myeloma)

Approved

Quarterly sales

Some catalyst date

You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
CNCT-19 (Anti-CD19) Details
Non-Hodgkin lymphoma

Phase 2

Update

Some catalyst date

You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
BI-1206 (Anti-FcyRIIB antibody) + rituximab Details
Solid tumor/s, Non-Hodgkin lymphoma, Blood cancer, Cancer

Phase 1/2

Update

Some catalyst date

You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
CB-5339 Details
Multiple myeloma

Phase 1

Data readout

Some catalyst date

You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.